Volume 86 Issue 38 | pp. 40-45
Issue Date: September 22, 2008

Preferred Contracts

Custom manufacturers of pharmaceutical actives and intermediates vie for a position in new big pharma supply chains
Department: Business

PHARMACEUTICAL fine chemicals manufacturers heading to Frankfurt later this month for CPhI, the conference on pharmaceutical ingredients, say business is looking up for the third year in a row. Having weathered a five-year downturn that saw the exit of several big chemical firms from the sector, they are optimistic about the opportunity for more business from emerging and biotech drug firms, as well as from major drug companies.

But the improved profitability may be more . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society